Professor Dr. Nina Bakracheva Petra A. ThürmannEmil GatchevSebastian Harder Special Article 06 August 2008 Pages: 835 - 836
Cytochromes P450, induction and cholesterol—what are the connections? Olavi PelkonenJukka Hakkola Editorial Commentary 17 July 2008 Pages: 837 - 839
Cytochrome P450 and gene activation—from pharmacology to cholesterol elimination and regression of atherosclerosis Pauli V. Luoma Review Article 17 July 2008 Pages: 841 - 850
Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature Thrasivoulos G. TzellosGeorgios PapazisisDimitrios Kouvelas Review Article 08 July 2008 Pages: 851 - 858
Slower onset of vasodilating action of brain natriuretic peptide (BNP) compared to atrial natriuretic peptide (ANP) in human forearm resistant vessels Hironobu MinamiTakanori YasuShinichiro Ueda Pharmacodynamics 12 July 2008 Pages: 859 - 862
Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson’s disease Frauke AdamsMichael BoschmannJens Jordan Pharmacodynamics 30 July 2008 Pages: 863 - 870
Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients Petra Bohanec GrabarBlaž RozmanVita Dolžan Pharmacogenetics 22 May 2008 Pages: 871 - 876
CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin Yuan GaoLi-rong ZhangQiang Fu Pharmacogenetics 05 June 2008 Pages: 877 - 882
Enantiospecific pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers and correlation with exercise-induced heart rate Angela SeeringerJürgen BrockmöllerJulia Kirchheiner Pharmacogenetics 11 June 2008 Pages: 883 - 888
VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients G. Oner OzgonT. Y. LangaeeJ. A. Johnson Pharmacogenetics 10 June 2008 Pages: 889 - 894
Plasma esterases and inflammation in ageing and frailty Ruth E. HubbardM. Sinead O’MahonyKen W. Woodhouse Pharmacokinetics and Disposition 28 May 2008 Pages: 895 - 900
Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers Adriana RochaEduardo B. CoelhoVera L. Lanchote Pharmacokinetics and Disposition 26 June 2008 Pages: 901 - 906
Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion H. MahtemeI. WallinH. Ehrsson Pharmacokinetics and Disposition Open access 18 June 2008 Pages: 907 - 911
Antibiotic drug use of children in the Netherlands from 1999 till 2005 Josta de JongPaul B. van den BergLolkje T. W. de Jong-van den Berg Pharmacoepidemiology and Prescription Open access 18 June 2008 Pages: 913 - 919
Incidence and risk factors for agranulocytosis in Latin American countries—the Latin Study Nelson HamerschlakEliane MalufRicardo Pasquini Pharmacoepidemiology and Prescription 26 June 2008 Pages: 921 - 929
Contrast-media-induced hypersensitivity or allergic/allergic-like reactions? Suggestion for a more appropriate use of the nomenclature Ingrid BöhmHans Schild Letter to the Editors 06 August 2008 Pages: 931 - 932
“Allergic-like/allergic” or “hypersensitivity” reactions? An open debate on ADR terminology Francesco LapiAlessandro MugelliAlfredo Vannacci Letter to the Editors 22 July 2008 Pages: 933 - 934